NPA, CRN, & the U.S. Hemp Roundtable were among those to offer testimony at the Congressional hearing "Hemp in the Modern World: The Years long Wait for FDA Action."

The Food and Drug Administration (FDA) has rejected a request by Rep. Jeff Duncan to hold a public hearing on FDA's position on NMN. FDA's stance: A public comment period would be sufficient on the matter. 

Making the Case for the safety of Dietary Supplements and Nutraceuticals

The Natural Products Association (NPA) once again gathered industry members in Washington, D.C. for a fly-in day to advocate on behalf of the natural products industry. 

The Council for Responsible Nutrition (CRN) has submitted a Citizen Petition to the U.S. Food and Drug Administration (FDA) calling for the agency to reconsider its interpretation of the Drug Preclusion Clause. 

In November 2022, a notification by the Food and Drug Administration (FDA) declared that beta-nicotinamide mononucleotide (NMN) is not a legal dietary ingredient. In response, the Natural Products Association (NPA), along with the Alliance for Natural Health (ANH), submitted a Citizen’s Petition to FDA.